Risk factors for multiple myeloma

A risk factor is something that increases the risk of developing cancer. It could be a behaviour, substance or condition. Most cancers are the result of many risk factors. But sometimes multiple myeloma develops in people who don’t have any of the risk factors described below.

More men than women are diagnosed with multiple myeloma. The risk for multiple myeloma increases with age. People of African ancestry have a higher risk of developing multiple myeloma. The reasons for this increased risk are not known.

Risk factors are generally listed in order from most to least important. But in most cases, it is impossible to rank them with absolute certainty.

Risk factors

History of monoclonal gammopathy of undetermined significance (MGUS)

Family history of multiple myeloma

Obesity and overweight

Farming

Weakened immune system

There is convincing evidence that the following factors increase your risk for multiple myeloma.

History of monoclonal gammopathy of undetermined significance (MGUS)

MGUS is a plasma cell disorder that has the potential to develop into multiple myeloma. A plasma cell is a type of white blood cell that makes antibodies to help the body fight infection. Many of the known and possible risk factors for MGUS are the same as for multiple myeloma.

It is difficult to diagnose multiple myeloma early. Often it causes no symptoms until it is more advanced. People with MGUS may have regular blood work to monitor for multiple myeloma.

Family history of multiple myeloma

Multiple myeloma is more common in some families. The risk of developing multiple myeloma is nearly 4 times greater for a person who has a parent or sibling with multiple myeloma. Some studies show that there is a stronger risk in families of African ancestry. But most people with multiple myeloma have no family history of the disease.

Obesity and overweight

Multiple myeloma occurs more often in people with a high body mass index (BMI) than in those who have a healthy weight.

Farming

Many studies show that people who work on a farm have a higher risk of developing multiple myeloma. We need more research to understand what it is about farming that causes the increase in risk. Some studies suggest that being exposed to certain pesticides used in farming explains the increased risk. Pesticides include a large number of different chemicals, but only some pesticides are linked to multiple myeloma risk. Research also shows that working with farm animals, especially sheep, may increase your risk. It may be that it is the combination of being exposed to pesticides, animals or other factors that increases a person’s chance of developing multiple myeloma.

Weakened immune system

People with a weakened immune system (immunosuppression) have a higher risk of developing multiple myeloma. This includes people with HIV or AIDS and people who have had an organ transplant and must take medicines to suppress their immune system.

Possible risk factors

The following factors have been linked with multiple myeloma, but there is not enough evidence to show for sure that they are risk factors. More research is needed to clarify the role of these factors for multiple myeloma:

  • autoimmune conditions
  • viral infections such as hepatitis B and C
  • working in occupations such as petroleum production, machinery production or carpentry, which expose you to chemicals such as benzene, coal or wood dust

Questions to ask your healthcare team

To make the decisions that are right for you, ask your healthcare team questions about risks.

Expert review and references

  • Anderson LA, Gadalla S, Morton LM, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. International Journal of Cancer. Hoboken, NJ: Wiley-Liss, Inc; 2009.
  • Apor E, O'Brien J, Stephen M, Castillo JJ. Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies. Leukemia Research. 2014.
  • Badras A. Epidemiology and risk factors of multiple myeloma: Insights into incidence and etiology. Sekeres, M. A., Kalaycio, M. E., & Bolwell, B. J. Clinical Malignant Hematology. New York: McGraw Hill Medical; 2007: IV(80): pp. 833-845.
  • Baris D, Morris Brown L, Andreotti G, Devesa SS. Epidemiology of multiple myeloma. Wiernik PH, Goldman JM, Dutcher JP, Kyle RA (eds.). Neoplastic Diseases of the Blood. 5th ed. Springer; 2013: 28: 547-564.
  • Becker N, Byl A, Friedrich S, Jauch A, Schnitzler P, Egerer G, et al. Hepatitis B virus infection is associated with deletion of chromosome 8p in multiple myeloma. European Journal of Haematology. 2013.
  • Becker N1, Schnitzler P, Boffetta P, Brennan P, Foretova L, Maynadie M, et al. Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph. Journal of Cancer Research and Clinical Oncology. 2012.
  • Bethwaite PB, Pearce N, Fraser J. Cancer risks in painters: study based on the New Zealand Cancer Registry. British Journal of Industrial Medicine. 1990.
  • Cardis E, Vrijheid M, Blettner M, et al. The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiation Research. Allen Press; 2007.
  • Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research; 2006.
  • Dal Maso L, Franceschi S.. Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncology. Elsevier; 2003.
  • Dispenzieri A, Lacy MQ, Kumar S. Multiple myeloma. Greer JP, Arber DA, Glader B, List AF, Means RT Jr, Paraskevas F, Rodgers GM, Foerster J, (eds.). Wintrobe's Clinical Hematology. 13th ed. Lippincott Williams & Wilkins; 2014: 98: 2046-2097.
  • Hofmann JN, Hoppin JA, Lynch CF, Poole JA, Purdue MP, Blair A, et al. Farm characteristics, allergy symptoms, and risk of non-hodgkin lymphoid neoplasms in the agricultural health study. Cancer Epidemiology, Biomarkers and Prevention. American Association for Cancer Research; 2015.
  • Hofmann JN, Moore SC, Lim U, Park Y, Baris D, Hollenbeck AR, et al. Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP diet and health study. American Journal of Epidemiology. 2013.
  • Hosgood HD 3rd, Baris D, Zhang Y, et al. Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk. Leukemia Research. Elsevier; 2009.
  • Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, et al. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001. Radiation Research. 2013.
  • International Agency for Research on Cancer (IARC). Volume 53: Occupational Exposures in Insecticide Application, and Some Pesticides. 1991. http://monographs.iarc.fr/ENG/Monographs/vol53/mono53.pdf.
  • International Agency for Research on Cancer (IARC). Volume 71: Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide. 1999. http://monographs.iarc.fr/ENG/Monographs/vol71/mono71.pdf.
  • International Agency for Research on Cancer (IARC). Volume 75: Ionizing Radiation Part 1: X- and Gamma (y)-Radiation, and Neutrons. 2000. http://monographs.iarc.fr/ENG/Monographs/vol75/mono75.pdf.
  • International Agency for Research on Cancer (IARC). Volume 77: Some Industrial Chemicals. 2000. http://monographs.iarc.fr/ENG/Monographs/vol77/mono77.pdf.
  • International Agency for Research on Cancer (IARC). Volume 97: 1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide). 2008. http://monographs.iarc.fr/ENG/Monographs/vol97/mono97.pdf.
  • International Agency for Research on Cancer (IARC). Volume 69: Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. 1997. http://monographs.iarc.fr/ENG/Monographs/vol69/mono69.pdf.
  • International Agency for Research on Cancer (IARC). Volume 47: Some organic solvents, resin monomers and related compounds, pigments and occupational exposures in paint manufacture and painting. 1989. http://monographs.iarc.fr/ENG/Monographs/vol47/mono47.pdf.
  • International Agency for Research on Cancer (IARC). Volume 99: Some Aromatic Amines, Organic Dyes, and Related Exposures. 2010. http://monographs.iarc.fr/ENG/Monographs/vol99/mono99.pdf.
  • International Agency for Research on Cancer (IARC). Volume 100D: Radiation: A Review of Human Carcinogens. 2011. http://monographs.iarc.fr/ENG/Monographs/vol100D/mono100D.pdf.
  • Khuder SA, Mutgi AB.. Meta-analyses of multiple myeloma and farming. American Journal of Industrial Medicine. Wiley-Liss; 1997.
  • Kim C, Bi X, Pan D, Chen Y, Carling T, Ma S, et al. The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. Thyroid. 2013.
  • Koutros S, Baris D, Bell E, et al. Use of hair colouring products and risk of multiple myeloma among US women. Occupational and Environmental Medicine. BMJ Publishing Group; 2009.
  • Kristinsson SY, Björkholm M, Goldin LR, et al. Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden. International Journal of Cancer. Hoboken, NJ: Wiley-Liss, Inc; 2009.
  • Kyle, R. A. & Rajkumar, S. V. Multiple myeloma. Ko, A. H., Dollinger, M., & Rosenbaum, E. Everyone's Guide to Cancer Therapy: How Cancer is Diagnosed, Treated and Managed Day to Day. 5th ed. Kansas City: Andrews McMeel Publishing; 2008: pp. 740-747.
  • Landgren O, Gridley G, Turesson I, et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood. American Society of Hematology;
  • Landgren O, Linet MS, McMaster ML, et al. Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study. International Journal of Cancer. Hoboken, NJ: Wiley-Liss, Inc; 2006.
  • Larsson SC, Wolk A.. Body mass index and risk of multiple myeloma: a meta-analysis. International Journal of Cancer. Hoboken, NJ: Wiley-Liss, Inc; 2007.
  • Linet MS, Harlow SD, McLaughlin JK.. A case-control study of multiple myeloma in whites: chronic antigenic stimulation, occupation, and drug use. Cancer Research. American Association for Cancer Research; 1987.
  • Liu T1, Xu QE, Zhang CH, Zhang P. Occupational exposure to methylene chloride and risk of cancer: a meta-analysis. Cancer Causes and Control.
  • McShane CM, Murray LJ, Engels EA, Landgren O, Anderson LA. Common community-acquired infections and subsequent risk of multiple myeloma: a population-based study. International Journal of Cancer. 2014.
  • McShane CM, Murray LJ, Landgren O, O'Rorke MA, Korde N, Kunzmann AT, et al. Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review. Cancer Epidemiology, Biomarkers and Prevention. American Association for Cancer Research; 2014.
  • Munshi NC & Anderson KC. Plasma Cell Neoplasms. Devita, V. T., Jr., Lawrence, T. S., & Rosenberg, S. A. Cancer: Principles & Practice of Oncology. 8th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008: 54:2305-2342.
  • Myeloma Canada. What Causes Myeloma. Kirkland, QC: 2015. https://www.myelomacanada.ca/.
  • National Cancer Institute. Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment PDQ®: Health Professional Version. National Cancer Institute; 2014. http://www.cancer.gov/cancertopics/pdq/treatment/myeloma/healthprofessional.
  • Perrotta C, Kleefeld S, Staines A, Tewari P, De Roos AJ, Baris D, et al. Multiple myeloma and occupation: a pooled analysis by the International Multiple Myeloma Consortium. Cancer Epidemiology. 2013.
  • Perrotta C, Staines A, Cocco P. Multiple myeloma and farming. A systematic review of 30 years of research. Where next?. Journal of Occupational Medicine and Toxicology. Biomed Central; 2008.
  • Perrotta C1, Staines A, Codd M, Kleefeld S, Crowley D, T' Mannetje A, et al. Multiple Myeloma and lifetime occupation: results from the EPILYMPH study. Journal of Occupational Medicine and Toxicology. Biomed Central; 2012.
  • Pottern LM, Gart JJ, Nam JM, et al. HLA and multiple myeloma among black and white men: evidence of a genetic association. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research; 1992.
  • Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiation Research. Allen Press; 1994.
  • Pukkala E, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Tryggvadottir L, et al. Cancer incidence among firefighters: 45 years of follow-up in five Nordic countries. Occupational and Environmental Medicine. 2014.
  • Purdue MP, Hofmann JN, Brown EE and Vachon CM. Multiple Myeloma. Thun MJ (ed.). Schottenfeld and Fraumeni Cancer Epidemiology and Prevention. 4th ed. New York, NY: Oxford University Press; 2018: 41: 797-814.
  • Raje N, Hideshima T, Anderson KC. Plasma cell tuours. Hong WK, Bast RC Jr, Hait WN, et al (eds.). Holland Frei Cancer Medicine. 8th ed. People's Medical Publishing House; 2010: 117: 1668-1685.
  • Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. British Medical Journal (BMJ). BMJ Publishing Group Ltd; 2007.
  • Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. New York, NY: Elsevier, Inc; 2008.
  • Shen K, Xu G, Wu Q, Zhou D, Li J. Risk of multiple myeloma in rheumatoid arthritis: a meta-analysis of case-control and cohort studies. PLoS One. Public Library of Science (PLoS); 2014.
  • Takkouche B, Regueira-Méndez C, Montes-Martínez A. Risk of cancer among hairdressers and related workers: a meta-analysis. International Journal of Epidemiology. Oxford, UK: Oxford Journals Oxford University Press; 2009.
  • Titmarsh GJ, McMullin MF, McShane CM, Clarke M, Engels EA, Anderson LA. Community-acquired infections and their association with myeloid malignancies. Cancer Epidemiology. 2014.

Reducing your risk for multiple myeloma

Ways to reduce your risk of multiple myeloma include maintaining a healthy body weight and eating well. Learn more about how to lower your risk of multiple myeloma.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society